Paxton Secures $720M from Drug Manufacturers for their Role in the Catastrophic Opioid Epidemic

Translate to Spanish or other 102 languages!

Attorney General Ken Paxton secured a new opioid settlement worth $720 million with eight drug makers that manufactured opioid pills and worsened the nationwide opioid crisis. In partnership with State Attorneys General across the country, this settlement will allow all local governments to participate through a sign-on period. The State of Texas and its political subdivisions could receive up to $45.5 million. Image for illustration purposes
Attorney General Ken Paxton secured a new opioid settlement worth $720 million with eight drug makers that manufactured opioid pills and worsened the nationwide opioid crisis. In partnership with State Attorneys General across the country, this settlement will allow all local governments to participate through a sign-on period. The State of Texas and its political subdivisions could receive up to $45.5 million. Image for illustration purposes
- Advertisement -

AUSTIN – Attorney General Ken Paxton secured a new opioid settlement worth $720 million with eight drug makers that manufactured opioid pills and worsened the nationwide opioid crisis. In partnership with State Attorneys General across the country, this settlement will allow all local governments to participate through a sign-on period. The State of Texas and its political subdivisions could receive up to $45.5 million. 

“These manufacturers played a role in creating one of the most destructive public health crises our country has ever faced,” said Attorney General Paxton. “These settlements are an important step in holding companies accountable for their reckless greed and the part they had in worsening the opioid epidemic, which has devastated our communities and poisoned countless Texans.” 

The eight defendants and the total amount they will pay in funds to address the opioid crisis as part of the deal are: 

- Advertisement -
  • Mylan (now a part of Viatris): $284,447,916 paid over nine years  
  • Hikma: $95,818,293 paid over one to four years  
  • Amneal: $71,751,010 paid over 10 years  
  • Apotex: $63,682,369 paid in a single year  
  • Indivior: $38,022,450 paid over four years  
  • Sun: $30,992,087 paid over one to four years  
  • Alvogen: $18,680,162 paid in a single year  
  • Zydus: $14,859,220 paid in a single year  

In addition to these abatement payments, the companies have also agreed to injunctive relief. Seven of the companies—not including Indivior—are prohibited from promoting or marketing opioid products, from making or selling any product that contains more than 40 mg of oxycodone per pill, and are required to put in place a monitoring and reporting system for suspicious orders. Indivior, for its part, has agreed to not manufacture or sell opioid products for the next 10 years, but it will be able to continue marketing and selling medications to treat opioid use disorder. 

Including this new settlement, Attorney General Paxton has obtained settlements committing nearly $3.34 billion in funds for Texas from companies that helped fuel the catastrophic opioid crisis.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS and Prominence Health Help Valley Seniors Outsmart Stroke

A stroke can strike without warning, leaving little time to react. Knowing the symptoms and seeking immediate medical care can significantly improve a person's chances of survival and long-term recovery.

$87 Million Poured Into Rural Healthcare Through New Grants

Governor Greg Abbott announced that the Texas Health and Human Services Commission (HHSC) plans to award $87 million in Rural Texas Strong grants to 129 rural healthcare providers throughout the state.

New Study Reveals Immune Protein Fights Cancer Alone

For decades, scientists have known that a protein made by T cells and natural killer (NK) cells in the immune system, called perforin, can kill tumor cells by punching a hole in the cell wall and injecting proteases called granzymes, which kill the cell.

A Mother’s Inspiration: STC Student Charts Her Path Toward a Nursing Career

At 19-years-old, Jennifer Cerda is already looking toward a future centered on caring for others, a goal inspired by the person who has always encouraged her the most: her mo
- Advertisement -